Xeltis has reported positive preliminary data for its Xabg coronary artery bypass conduit (CABG) in a trial that is underway at EU sites.

Saluda Medical has announced the full US commercial launch of its EVA sensing technology intended for scanning and analysing the spinal cord.

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software.

Viome, with Scripps Research, is set to develop and clinically validate the first RNA test for detecting precancerous colon polyps.

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

The medical device industry faces being pulled into a broader contest over control, sovereignty and industrial self-sufficiency.

Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.

Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.

The US FDA has cleared Intuitive's Vessel Sealer Curved for use with the company’s multiport da Vinci surgical systems.

Researchers at the University of Queensland (UQ) have developed a new device to facilitate drug delivery into the brain safely.

Medtronic has secured EU CE mark approval for LigaSure RAS, a vessel-sealing instrument for use with the company’s Hugo robotic-assisted surgery (RAS) system.